MedPath

Exploratory study on nasal high flow therapy for breath hold in radiotherapy (ENTheR-study)

Completed
Conditions
10027655
lung and breast cancer
Registration Number
NL-OMON46151
Lead Sponsor
MAASTRO clinic
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

- Locally advanced lung cancer or oligometastatic patients with *local* stage III, treated with curative or radical intent OR
- Left-sided breast cancer patients treated with radiotherapy with curative intent.
- WHO* 2
- * 18 years old
- Able to give informed consent
- Willing to be treated in Maastricht (treatment not possible in Venlo)

Exclusion Criteria

- Patient refusal
- Hypercapnic COPD patient

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath